APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cardiovascular Device Testing Service

Compare research editions
View pricing & licenses

Selected research

Industry Research

Cardiovascular Device Testing Service Industry Research Report 2026

15 April 2026138 pages

Choose your research edition.

Industry ResearchCardiovascular Device Testing Service Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiovascular Device Testing Service Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Cardiovascular Device Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiovascular Device Testing Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Cardiovascular Device Testing Service Market Analysis and Forecast 2026-2032226 pages · $4,950 USD

Market perspective

The global Cardiovascular Device Testing Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Cardiovascular Device Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cardiovascular Device Testing Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cardiovascular Device Testing Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cardiovascular Device Testing Service include TÜV SÜD, ViVitro Labs, STC Group, Intertek, NAMSA, BDC Laboratories, MET Labs, SGS SA and Nelson Labs, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Cardiovascular Device Testing Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cardiovascular Device Testing Service.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Cardiovascular Device Testing Service Market by Company

TÜV SÜD

ViVitro Labs

STC Group

Intertek

NAMSA

BDC Laboratories

MET Labs

SGS SA

Nelson Labs

Charles River Laboratories

UL Solutions

MED Institute

Eurofins Scientific

Pharmaron

Pace Analytical

Porsolt

Medical Murray

Measurlabs

RQM+

Laboratory Testing

Infinity Laboratories

Ibex Preclinical Research

Innovatech Labs

Cardiovascular Device Testing Service Segment by Type

Mechanical Testing

Physical Testing

Environmental Testing

Biocompatibility Testing

Performance Testing

Electromagnetic Compatibility (EMC) Testing

Preclinical Testing

Clinical Testing

Others

Cardiovascular Device Testing Service Segment by Application

Interventional Devices

Implantable Devices

Diagnostic and Monitoring Devices

Extracorporeal Circulation and Support Devices

Vascular Access and Suture Devices

Others

Cardiovascular Device Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiovascular Device Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiovascular Device Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiovascular Device Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Cardiovascular Device Testing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cardiovascular Device Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Cardiovascular Device Testing Service Revenue Market Share by Type (2021-2026) Table 7. Global Cardiovascular Device Testing Service Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Cardiovascular Device Testing Service Revenue Market Share by Type (2027-2032) Table 9. Global Cardiovascular Device Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Cardiovascular Device Testing Service Revenue Market Share by Application (2021-2026) Table 11. Global Cardiovascular Device Testing Service Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Cardiovascular Device Testing Service Revenue Market Share by Application (2027-2032) Table 13. Global Cardiovascular Device Testing Service Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Cardiovascular Device Testing Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Cardiovascular Device Testing Service Market Share by Region (2021-2026) Table 16. Global Cardiovascular Device Testing Service Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Cardiovascular Device Testing Service Market Share by Region (2027-2032) Table 18. Cardiovascular Device Testing Service Industry Trends Table 19. Cardiovascular Device Testing Service Industry Drivers Table 20. Cardiovascular Device Testing Service Industry Opportunities and Challenges Table 21. Cardiovascular Device Testing Service Market Restraints Table 22. Global Top Cardiovascular Device Testing Service Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Cardiovascular Device Testing Service Revenue Market Share by Players (2021-2026) Table 24. Global Cardiovascular Device Testing Service Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Cardiovascular Device Testing Service, Headquarters and Area Served Table 26. Global Cardiovascular Device Testing Service Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Cardiovascular Device Testing Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Cardiovascular Device Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Cardiovascular Device Testing Service Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Cardiovascular Device Testing Service Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Cardiovascular Device Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Cardiovascular Device Testing Service Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Cardiovascular Device Testing Service Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Cardiovascular Device Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Cardiovascular Device Testing Service Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Cardiovascular Device Testing Service Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Cardiovascular Device Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Cardiovascular Device Testing Service Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Cardiovascular Device Testing Service Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Cardiovascular Device Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Cardiovascular Device Testing Service Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Cardiovascular Device Testing Service Market Size by Country (2027-2032) & (US$ Million) Table 45. TÜV SÜD Company Information Table 46. TÜV SÜD Business Overview Table 47. TÜV SÜD Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 48. TÜV SÜD Cardiovascular Device Testing Service Product Portfolio Table 49. TÜV SÜD Recent Developments Table 50. ViVitro Labs Company Information Table 51. ViVitro Labs Business Overview Table 52. ViVitro Labs Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 53. ViVitro Labs Cardiovascular Device Testing Service Product Portfolio Table 54. ViVitro Labs Recent Developments Table 55. STC Group Company Information Table 56. STC Group Business Overview Table 57. STC Group Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 58. STC Group Cardiovascular Device Testing Service Product Portfolio Table 59. STC Group Recent Developments Table 60. Intertek Company Information Table 61. Intertek Business Overview Table 62. Intertek Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 63. Intertek Cardiovascular Device Testing Service Product Portfolio Table 64. Intertek Recent Developments Table 65. NAMSA Company Information Table 66. NAMSA Business Overview Table 67. NAMSA Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 68. NAMSA Cardiovascular Device Testing Service Product Portfolio Table 69. NAMSA Recent Developments Table 70. BDC Laboratories Company Information Table 71. BDC Laboratories Business Overview Table 72. BDC Laboratories Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 73. BDC Laboratories Cardiovascular Device Testing Service Product Portfolio Table 74. BDC Laboratories Recent Developments Table 75. MET Labs Company Information Table 76. MET Labs Business Overview Table 77. MET Labs Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 78. MET Labs Cardiovascular Device Testing Service Product Portfolio Table 79. MET Labs Recent Developments Table 80. SGS SA Company Information Table 81. SGS SA Business Overview Table 82. SGS SA Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 83. SGS SA Cardiovascular Device Testing Service Product Portfolio Table 84. SGS SA Recent Developments Table 85. Nelson Labs Company Information Table 86. Nelson Labs Business Overview Table 87. Nelson Labs Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 88. Nelson Labs Cardiovascular Device Testing Service Product Portfolio Table 89. Nelson Labs Recent Developments Table 90. Charles River Laboratories Company Information Table 91. Charles River Laboratories Business Overview Table 92. Charles River Laboratories Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 93. Charles River Laboratories Cardiovascular Device Testing Service Product Portfolio Table 94. Charles River Laboratories Recent Developments Table 95. UL Solutions Company Information Table 96. UL Solutions Business Overview Table 97. UL Solutions Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 98. UL Solutions Cardiovascular Device Testing Service Product Portfolio Table 99. UL Solutions Recent Developments Table 100. MED Institute Company Information Table 101. MED Institute Business Overview Table 102. MED Institute Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 103. MED Institute Cardiovascular Device Testing Service Product Portfolio Table 104. MED Institute Recent Developments Table 105. Eurofins Scientific Company Information Table 106. Eurofins Scientific Business Overview Table 107. Eurofins Scientific Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 108. Eurofins Scientific Cardiovascular Device Testing Service Product Portfolio Table 109. Eurofins Scientific Recent Developments Table 110. Pharmaron Company Information Table 111. Pharmaron Business Overview Table 112. Pharmaron Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 113. Pharmaron Cardiovascular Device Testing Service Product Portfolio Table 114. Pharmaron Recent Developments Table 115. Pace Analytical Company Information Table 116. Pace Analytical Business Overview Table 117. Pace Analytical Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 118. Pace Analytical Cardiovascular Device Testing Service Product Portfolio Table 119. Pace Analytical Recent Developments Table 120. Porsolt Company Information Table 121. Porsolt Business Overview Table 122. Porsolt Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 123. Porsolt Cardiovascular Device Testing Service Product Portfolio Table 124. Porsolt Recent Developments Table 125. Medical Murray Company Information Table 126. Medical Murray Business Overview Table 127. Medical Murray Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 128. Medical Murray Cardiovascular Device Testing Service Product Portfolio Table 129. Medical Murray Recent Developments Table 130. Measurlabs Company Information Table 131. Measurlabs Business Overview Table 132. Measurlabs Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 133. Measurlabs Cardiovascular Device Testing Service Product Portfolio Table 134. Measurlabs Recent Developments Table 135. RQM+ Company Information Table 136. RQM+ Business Overview Table 137. RQM+ Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 138. RQM+ Cardiovascular Device Testing Service Product Portfolio Table 139. RQM+ Recent Developments Table 140. Laboratory Testing Company Information Table 141. Laboratory Testing Business Overview Table 142. Laboratory Testing Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 143. Laboratory Testing Cardiovascular Device Testing Service Product Portfolio Table 144. Laboratory Testing Recent Developments Table 145. Infinity Laboratories Company Information Table 146. Infinity Laboratories Business Overview Table 147. Infinity Laboratories Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 148. Infinity Laboratories Cardiovascular Device Testing Service Product Portfolio Table 149. Infinity Laboratories Recent Developments Table 150. Ibex Preclinical Research Company Information Table 151. Ibex Preclinical Research Business Overview Table 152. Ibex Preclinical Research Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 153. Ibex Preclinical Research Cardiovascular Device Testing Service Product Portfolio Table 154. Ibex Preclinical Research Recent Developments Table 155. Innovatech Labs Company Information Table 156. Innovatech Labs Business Overview Table 157. Innovatech Labs Revenue in Cardiovascular Device Testing Service Business (2021-2026) & (US$ Million) Table 158. Innovatech Labs Cardiovascular Device Testing Service Product Portfolio Table 159. Innovatech Labs Recent Developments Table 160. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Cardiovascular Device Testing Service Product Image Figure 5. Global Cardiovascular Device Testing Service Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Cardiovascular Device Testing Service Market Share by Type: 2025 VS 2032 Figure 7. Mechanical Testing Product Figure 8. Physical Testing Product Figure 9. Environmental Testing Product Figure 10. Biocompatibility Testing Product Figure 11. Performance Testing Product Figure 12. Electromagnetic Compatibility (EMC) Testing Product Figure 13. Preclinical Testing Product Figure 14. Clinical Testing Product Figure 15. Others Product Figure 16. Global Cardiovascular Device Testing Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Cardiovascular Device Testing Service Market Share by Application: 2025 VS 2032 Figure 18. Interventional Devices Product Figure 19. Implantable Devices Product Figure 20. Diagnostic and Monitoring Devices Product Figure 21. Extracorporeal Circulation and Support Devices Product Figure 22. Vascular Access and Suture Devices Product Figure 23. Others Product Figure 24. Global Cardiovascular Device Testing Service Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 25. Global Cardiovascular Device Testing Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 26. Global Cardiovascular Device Testing Service Market Share by Region: 2025 VS 2032 Figure 27. Global Cardiovascular Device Testing Service Market Share by Players in 2025 Figure 28. Global Cardiovascular Device Testing Service Manufacturers Established Date Figure 29. Global Top 5 and 10 Cardiovascular Device Testing Service Players Market Share by Revenue in 2025 Figure 30. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. North America Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. North America Cardiovascular Device Testing Service Market Share by Country (2021-2032) Figure 33. United States Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Canada Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Mexico Cardiovascular Device Testing Service Market Share by Country (2021-2032) Figure 36. Europe Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Europe Cardiovascular Device Testing Service Market Share by Country (2021-2032) Figure 38. Germany Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. France Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. U.K. Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Italy Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. Spain Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. Russia Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. Netherlands Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. Nordic Countries Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia-Pacific Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia-Pacific Cardiovascular Device Testing Service Market Share by Country (2021-2032) Figure 48. China Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. Japan Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. South Korea Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. India Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. India Cardiovascular Device Testing Service Market Share by Country (2021-2032) Figure 53. Australia Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. China Taiwan Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. Southeast Asia Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 56. South America Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 57. South America Cardiovascular Device Testing Service Market Share by Country (2021-2032) Figure 58. Brazil Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 59. Argentina Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 60. Chile Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 61. Colombia Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 62. Peru Cardiovascular Device Testing Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 63. TÜV SÜD Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 64. ViVitro Labs Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 65. STC Group Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 66. Intertek Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 67. NAMSA Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 68. BDC Laboratories Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 69. MET Labs Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 70. SGS SA Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 71. Nelson Labs Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 72. Charles River Laboratories Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 73. UL Solutions Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 74. MED Institute Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 75. Eurofins Scientific Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 76. Pharmaron Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 77. Pace Analytical Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 78. Porsolt Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 79. Medical Murray Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 80. Measurlabs Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 81. RQM+ Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 82. Laboratory Testing Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 83. Infinity Laboratories Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 84. Ibex Preclinical Research Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026) Figure 85. Innovatech Labs Revenue Growth Rate in Cardiovascular Device Testing Service Business (2021-2026)

Scope & coverage.

Types
  • Mechanical Testing
  • Physical Testing
  • Environmental Testing
  • Biocompatibility Testing
  • Performance Testing
  • Electromagnetic Compatibility (EMC) Testing
  • Preclinical Testing
  • Clinical Testing
  • Others
Applications
  • Interventional Devices
  • Implantable Devices
  • Diagnostic and Monitoring Devices
  • Extracorporeal Circulation and Support Devices
  • Vascular Access and Suture Devices
  • Others
Companies covered
  • TÜV SÜD
  • ViVitro Labs
  • STC Group
  • Intertek
  • NAMSA
  • BDC Laboratories
  • MET Labs
  • SGS SA
  • Nelson Labs
  • Charles River Laboratories
  • UL Solutions
  • MED Institute
  • Eurofins Scientific
  • Pharmaron
  • Pace Analytical
  • Porsolt
  • Medical Murray
  • Measurlabs
  • RQM+
  • Laboratory Testing
  • Infinity Laboratories
  • Ibex Preclinical Research
  • Innovatech Labs

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Cardiovascular Device Testing Service by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Mechanical Testing
  5. 2.2.3 Physical Testing
  6. 2.2.4 Environmental Testing
  7. 2.2.5 Biocompatibility Testing
  8. 2.2.6 Performance Testing
  9. 2.2.7 Electromagnetic Compatibility (EMC) Testing
  10. 2.2.8 Preclinical Testing
  11. 2.2.9 Clinical Testing
  12. 2.2.10 Others
  13. 2.3 Cardiovascular Device Testing Service by Application
  14. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.3.2 Interventional Devices
  16. 2.3.3 Implantable Devices
  17. 2.3.4 Diagnostic and Monitoring Devices
  18. 2.3.5 Extracorporeal Circulation and Support Devices
  19. 2.3.6 Vascular Access and Suture Devices
  20. 2.3.7 Others
  21. 2.4 Assumptions and Limitations
3 Cardiovascular Device Testing Service Breakdown Data by Type
  1. 3.1 Global Cardiovascular Device Testing Service Historic Market Size by Type (2021-2026)
  2. 3.2 Global Cardiovascular Device Testing Service Forecasted Market Size by Type (2027-2032)
4 Cardiovascular Device Testing Service Breakdown Data by Application
  1. 4.1 Global Cardiovascular Device Testing Service Historic Market Size by Application (2021-2026)
  2. 4.2 Global Cardiovascular Device Testing Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Cardiovascular Device Testing Service Market Perspective (2021-2032)
  2. 5.2 Global Cardiovascular Device Testing Service Growth Trends by Region
  3. 5.2.1 Global Cardiovascular Device Testing Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Cardiovascular Device Testing Service Historic Market Size by Region (2021-2026)
  5. 5.2.3 Cardiovascular Device Testing Service Forecasted Market Size by Region (2027-2032)
  6. 5.3 Cardiovascular Device Testing Service Market Dynamics
  7. 5.3.1 Cardiovascular Device Testing Service Industry Trends
  8. 5.3.2 Cardiovascular Device Testing Service Market Drivers
  9. 5.3.3 Cardiovascular Device Testing Service Market Challenges
  10. 5.3.4 Cardiovascular Device Testing Service Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Cardiovascular Device Testing Service Players by Revenue
  2. 6.1.1 Global Top Cardiovascular Device Testing Service Players by Revenue (2021-2026)
  3. 6.1.2 Global Cardiovascular Device Testing Service Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Cardiovascular Device Testing Service Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Cardiovascular Device Testing Service Head Office and Area Served
  6. 6.4 Global Cardiovascular Device Testing Service Players, Product Type & Application
  7. 6.5 Global Cardiovascular Device Testing Service Manufacturers Established Date
  8. 6.6 Global Cardiovascular Device Testing Service Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Cardiovascular Device Testing Service Market Size (2021-2032)
  2. 7.2 North America Cardiovascular Device Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Cardiovascular Device Testing Service Market Size by Country (2021-2026)
  4. 7.4 North America Cardiovascular Device Testing Service Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Cardiovascular Device Testing Service Market Size (2021-2032)
  2. 8.2 Europe Cardiovascular Device Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Cardiovascular Device Testing Service Market Size by Country (2021-2026)
  4. 8.4 Europe Cardiovascular Device Testing Service Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Cardiovascular Device Testing Service Market Size (2021-2032)
  2. 9.2 Asia-Pacific Cardiovascular Device Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Cardiovascular Device Testing Service Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Cardiovascular Device Testing Service Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Cardiovascular Device Testing Service Market Size (2021-2032)
  2. 10.2 South America Cardiovascular Device Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Cardiovascular Device Testing Service Market Size by Country (2021-2026)
  4. 10.4 South America Cardiovascular Device Testing Service Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Cardiovascular Device Testing Service Market Size (2021-2032)
  2. 11.2 Middle East & Africa Cardiovascular Device Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Cardiovascular Device Testing Service Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Cardiovascular Device Testing Service Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 TÜV SÜD
  2. 12.1.1 TÜV SÜD Company Information
  3. 12.1.2 TÜV SÜD Business Overview
  4. 12.1.3 TÜV SÜD Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  5. 12.1.4 TÜV SÜD Cardiovascular Device Testing Service Product Portfolio
  6. 12.1.5 TÜV SÜD Recent Developments
  7. 12.2 ViVitro Labs
  8. 12.2.1 ViVitro Labs Company Information
  9. 12.2.2 ViVitro Labs Business Overview
  10. 12.2.3 ViVitro Labs Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  11. 12.2.4 ViVitro Labs Cardiovascular Device Testing Service Product Portfolio
  12. 12.2.5 ViVitro Labs Recent Developments
  13. 12.3 STC Group
  14. 12.3.1 STC Group Company Information
  15. 12.3.2 STC Group Business Overview
  16. 12.3.3 STC Group Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  17. 12.3.4 STC Group Cardiovascular Device Testing Service Product Portfolio
  18. 12.3.5 STC Group Recent Developments
  19. 12.4 Intertek
  20. 12.4.1 Intertek Company Information
  21. 12.4.2 Intertek Business Overview
  22. 12.4.3 Intertek Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  23. 12.4.4 Intertek Cardiovascular Device Testing Service Product Portfolio
  24. 12.4.5 Intertek Recent Developments
  25. 12.5 NAMSA
  26. 12.5.1 NAMSA Company Information
  27. 12.5.2 NAMSA Business Overview
  28. 12.5.3 NAMSA Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  29. 12.5.4 NAMSA Cardiovascular Device Testing Service Product Portfolio
  30. 12.5.5 NAMSA Recent Developments
  31. 12.6 BDC Laboratories
  32. 12.6.1 BDC Laboratories Company Information
  33. 12.6.2 BDC Laboratories Business Overview
  34. 12.6.3 BDC Laboratories Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  35. 12.6.4 BDC Laboratories Cardiovascular Device Testing Service Product Portfolio
  36. 12.6.5 BDC Laboratories Recent Developments
  37. 12.7 MET Labs
  38. 12.7.1 MET Labs Company Information
  39. 12.7.2 MET Labs Business Overview
  40. 12.7.3 MET Labs Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  41. 12.7.4 MET Labs Cardiovascular Device Testing Service Product Portfolio
  42. 12.7.5 MET Labs Recent Developments
  43. 12.8 SGS SA
  44. 12.8.1 SGS SA Company Information
  45. 12.8.2 SGS SA Business Overview
  46. 12.8.3 SGS SA Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  47. 12.8.4 SGS SA Cardiovascular Device Testing Service Product Portfolio
  48. 12.8.5 SGS SA Recent Developments
  49. 12.9 Nelson Labs
  50. 12.9.1 Nelson Labs Company Information
  51. 12.9.2 Nelson Labs Business Overview
  52. 12.9.3 Nelson Labs Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  53. 12.9.4 Nelson Labs Cardiovascular Device Testing Service Product Portfolio
  54. 12.9.5 Nelson Labs Recent Developments
  55. 12.10 Charles River Laboratories
  56. 12.10.1 Charles River Laboratories Company Information
  57. 12.10.2 Charles River Laboratories Business Overview
  58. 12.10.3 Charles River Laboratories Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  59. 12.10.4 Charles River Laboratories Cardiovascular Device Testing Service Product Portfolio
  60. 12.10.5 Charles River Laboratories Recent Developments
  61. 12.11 UL Solutions
  62. 12.11.1 UL Solutions Company Information
  63. 12.11.2 UL Solutions Business Overview
  64. 12.11.3 UL Solutions Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  65. 12.11.4 UL Solutions Cardiovascular Device Testing Service Product Portfolio
  66. 12.11.5 UL Solutions Recent Developments
  67. 12.12 MED Institute
  68. 12.12.1 MED Institute Company Information
  69. 12.12.2 MED Institute Business Overview
  70. 12.12.3 MED Institute Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  71. 12.12.4 MED Institute Cardiovascular Device Testing Service Product Portfolio
  72. 12.12.5 MED Institute Recent Developments
  73. 12.13 Eurofins Scientific
  74. 12.13.1 Eurofins Scientific Company Information
  75. 12.13.2 Eurofins Scientific Business Overview
  76. 12.13.3 Eurofins Scientific Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  77. 12.13.4 Eurofins Scientific Cardiovascular Device Testing Service Product Portfolio
  78. 12.13.5 Eurofins Scientific Recent Developments
  79. 12.14 Pharmaron
  80. 12.14.1 Pharmaron Company Information
  81. 12.14.2 Pharmaron Business Overview
  82. 12.14.3 Pharmaron Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  83. 12.14.4 Pharmaron Cardiovascular Device Testing Service Product Portfolio
  84. 12.14.5 Pharmaron Recent Developments
  85. 12.15 Pace Analytical
  86. 12.15.1 Pace Analytical Company Information
  87. 12.15.2 Pace Analytical Business Overview
  88. 12.15.3 Pace Analytical Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  89. 12.15.4 Pace Analytical Cardiovascular Device Testing Service Product Portfolio
  90. 12.15.5 Pace Analytical Recent Developments
  91. 12.16 Porsolt
  92. 12.16.1 Porsolt Company Information
  93. 12.16.2 Porsolt Business Overview
  94. 12.16.3 Porsolt Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  95. 12.16.4 Porsolt Cardiovascular Device Testing Service Product Portfolio
  96. 12.16.5 Porsolt Recent Developments
  97. 12.17 Medical Murray
  98. 12.17.1 Medical Murray Company Information
  99. 12.17.2 Medical Murray Business Overview
  100. 12.17.3 Medical Murray Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  101. 12.17.4 Medical Murray Cardiovascular Device Testing Service Product Portfolio
  102. 12.17.5 Medical Murray Recent Developments
  103. 12.18 Measurlabs
  104. 12.18.1 Measurlabs Company Information
  105. 12.18.2 Measurlabs Business Overview
  106. 12.18.3 Measurlabs Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  107. 12.18.4 Measurlabs Cardiovascular Device Testing Service Product Portfolio
  108. 12.18.5 Measurlabs Recent Developments
  109. 12.19 RQM+
  110. 12.19.1 RQM+ Company Information
  111. 12.19.2 RQM+ Business Overview
  112. 12.19.3 RQM+ Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  113. 12.19.4 RQM+ Cardiovascular Device Testing Service Product Portfolio
  114. 12.19.5 RQM+ Recent Developments
  115. 12.20 Laboratory Testing
  116. 12.20.1 Laboratory Testing Company Information
  117. 12.20.2 Laboratory Testing Business Overview
  118. 12.20.3 Laboratory Testing Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  119. 12.20.4 Laboratory Testing Cardiovascular Device Testing Service Product Portfolio
  120. 12.20.5 Laboratory Testing Recent Developments
  121. 12.21 Infinity Laboratories
  122. 12.21.1 Infinity Laboratories Company Information
  123. 12.21.2 Infinity Laboratories Business Overview
  124. 12.21.3 Infinity Laboratories Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  125. 12.21.4 Infinity Laboratories Cardiovascular Device Testing Service Product Portfolio
  126. 12.21.5 Infinity Laboratories Recent Developments
  127. 12.22 Ibex Preclinical Research
  128. 12.22.1 Ibex Preclinical Research Company Information
  129. 12.22.2 Ibex Preclinical Research Business Overview
  130. 12.22.3 Ibex Preclinical Research Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  131. 12.22.4 Ibex Preclinical Research Cardiovascular Device Testing Service Product Portfolio
  132. 12.22.5 Ibex Preclinical Research Recent Developments
  133. 12.23 Innovatech Labs
  134. 12.23.1 Innovatech Labs Company Information
  135. 12.23.2 Innovatech Labs Business Overview
  136. 12.23.3 Innovatech Labs Revenue in Cardiovascular Device Testing Service Business (2021-2026)
  137. 12.23.4 Innovatech Labs Cardiovascular Device Testing Service Product Portfolio
  138. 12.23.5 Innovatech Labs Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst